Cargando…
Summary of the National Advisory Committee on Immunization (NACI) Rapid Response—Interim guidance on the use of Imvamune in the context of monkeypox outbreaks in Canada
BACKGROUND: Monkeypox is endemic in Central and West Africa. Cases in non-endemic countries, including Canada, have been increasing since May 2022. Imvamune(®), a live, non-replicating smallpox vaccine, was approved by Health Canada for active immunization against smallpox and monkeypox infections a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Health Agency of Canada
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324881/ https://www.ncbi.nlm.nih.gov/pubmed/37426289 http://dx.doi.org/10.14745/ccdr.v48i78a09 |